Document:

EXHIBIT 4.2
                                                                     -----------

THE  WARRANT  AND  THE  SECURITIES   ISSUABLE  UPON  EXERCISE  OF  THIS  WARRANT
(COLLECTIVELY,  THE "SECURITIES")  HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE SECURITIES OR
BLUE  SKY LAWS  ("BLUE  SKY  LAWS").  NO  TRANSFER,  SALE,  ASSIGNMENT,  PLEDGE,
HYPOTHECATION  OR OTHER  DISPOSITION  OF THIS WARRANT OR THE  SECURITIES  OR ANY
INTEREST  THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN  EFFECTIVE  REGISTRATION
STATEMENT  UNDER THE SECURITIES  ACT AND ANY APPLICABLE  BLUE SKY LAWS OR (B) IF
THE COMPANY HAS BEEN  FURNISHED  WITH BOTH AN OPINION OF COUNSEL FOR THE HOLDER,
WHICH OPINION AND COUNSEL SHALL BE  SATISFACTORY  TO THE COMPANY,  TO THE EFFECT
THAT NO  REGISTRATION  IS REQUIRED  BECAUSE OF THE  AVAILABILITY OF AN EXEMPTION
FROM  REGISTRATION  UNDER THE SECURITIES  ACT AND APPLICABLE  BLUE SKY LAWS, AND
ASSURANCES THAT THE TRANSFER, SALE, ASSIGNMENT,  PLEDGE,  HYPOTHECATION OR OTHER
DISPOSITION  WILL BE MADE ONLY IN  COMPLIANCE  WITH THE  CONDITIONS  OF ANY SUCH
REGISTRATION OR EXEMPTION.

                   WARRANT TO PURCHASE SHARES OF COMMON STOCK
                                       OF
                             PROUROCARE MEDICAL INC.

Warrant No. 23                                               Plymouth, Minnesota
                                                                   April 5, 2004

     THIS CERTIFIES THAT, for value received, BINA Enterprises or its successors
or assigns (collectively,  the "Holder") is entitled to purchase from ProUroCare
Medical Inc. (the "Company"),  Three Hundred  Thousand  (300,000) fully paid and
nonassessable  shares (the  "Shares") of the Company's  common  stock,  $.01 par
value (the  "Common  Stock"),  at an  exercise  price of Two  Dollars and No/100
($2.00)  per Share  (the  "Exercise  Price"),  subject to  adjustment  as herein
provided.  This  Warrant may be  exercised  by Holder at any time after the date
hereof;  provided,  however,  that,  Holder  shall in no event have the right to
exercise  this  Warrant or any portion  thereof  after three years from the date
hereof, at which time all of Holder's rights hereunder shall expire.

     This Warrant is subject to the following provisions, terms and conditions:

     1.  Exercise  of Warrant.  The rights  represented  by this  Warrant may be
exercised  by the  Holder,  in  whole or in part  (but not as to any  fractional
shares of Common Stock), by the surrender of this Warrant (properly endorsed, if
required,  at the Company's  principal  office in Plymouth,  Minnesota,  or such
other office or agency of the Company as the Company may  designate by notice in
writing to the Holder at the  address of such Holder  appearing  on the books of
the Company at any time within the period above  named),  and upon payment to it
by certified  check,  bank draft or cash of the purchase  price for such Shares.
The Company agrees that the Shares so purchased  shall be deemed to be issued to
the Holder as the record owner of such Shares as of the close of business on the
date on which this  Warrant  shall have been  surrendered  and  payment for such
Shares  shall  have  been  made as  aforesaid.  Certificates  for the  Shares so
purchased  shall be  delivered  to the  Holder  within a  reasonable  time,  not
exceeding 30 days, after the rights  represented by this Warrant shall have been
so exercised and,  unless this Warrant has expired,  a new Warrant  representing
the number of Shares,  if any, with respect to which this Warrant shall not then
have been exercised  shall also be delivered to the Holder within such time. The
Company may  require  that any such new  Warrant or any  certificate  for Shares
purchased upon the exercise hereof bear a legend  substantially  similar to that
which is contained on the face of this Warrant.

<PAGE>

     2.  Transferability  of this  Warrant.  This  Warrant  is  issued  upon the
following terms, to which Holder consents and agrees:

     (a) Until this  Warrant is  transferred  on the books of the  Company,  the
Company will treat the Holder of this  Warrant,  registered as such on the books
of the Company,  as the absolute  owner hereof for all purposes  without  effect
given to any notice to the contrary.

     (b) This  Warrant  may not be  exercised,  and this  Warrant and the Shares
underlying this Warrant shall not be transferable, except in compliance with all
applicable state and federal  securities laws,  regulations and orders, and with
all other applicable laws, regulations and orders.

     (c) The  Warrant  may not be  transferred,  and the  Shares  issuable  upon
exercise of this Warrant, may not be transferred without the Holder obtaining an
opinion of counsel,  which opinion and counsel are  satisfactory to the Company,
stating  that  the  proposed   transaction  will  not  result  in  a  prohibited
transaction  under the Securities Act and applicable Blue Sky Laws. By accepting
this Warrant, the Holder agrees to act in accordance with any conditions imposed
on such transfer by any such opinion of counsel.

     (d) Neither the  issuance  of this  Warrant nor the  issuance of the Shares
issuable upon exercise of this Warrant have been registered under the Securities
Act.

     3. Certain Covenants of the Company.  The Company covenants and agrees that
all Shares  which may be issued upon the exercise of the rights  represented  by
this Warrant,  upon issuance and full payment for the Shares so purchased,  will
be duly authorized and issued,  fully paid and  nonassessable  and free from all
taxes, liens and charges with respect to the issue hereof, except those that may
be created by or imposed upon the Holder or its property;  and, without limiting
the generality of the foregoing,  the Company  covenants and agrees that it will
from time to time take all such  actions as may be  required  to ensure that the
par value per share of the  Common  Stock is at all times  equal to or less than
the Exercise  Price per Share  issuable  pursuant to this  Warrant.  The Company
further  covenants  and agrees  that during the period  within  which the rights
represented by this Warrant may be exercised, the Company will at all times have
authorized and reserved,  free of preemptive or other rights, for the purpose of
issue  upon  exercise  of the  purchase  rights  evidenced  by this  Warrant,  a
sufficient number of shares of its Common Stock to provide for the full exercise
of the rights represented by this Warrant.

     4.  Adjustment of Exercise  Price and Number of Shares.  The Exercise Price
and number of Shares are subject to the following adjustments:

     (a) Stock Dividend, Stock Split or Stock Combination.  If (i) any dividends
on any  class  of the  Company's  capital  stock  payable  in  Common  Stock  or
securities  convertible  into or  exercisable  for Common  Stock  (collectively,
"Common Stock Equivalents") shall be paid by the Company, (ii) the Company shall
divide its  then-outstanding  shares of Common  Stock  into a greater  number of
shares,  or (iii) the Company  shall  combine its  outstanding  shares of Common
Stock, by reclassification  or otherwise,  then, in any such event, the Exercise
Price in effect  immediately  prior to such event shall  (until  adjusted  again
pursuant hereto) be adjusted immediately after such event to a price (calculated
to the nearest  full cent) equal to the  quotient of (x) the number of shares of
Common Stock  outstanding  immediately  prior to such event,  multiplied  by the
Exercise  Price in effect  immediately  prior to such event,  divided by (y) the
total number of shares of Common Stock outstanding immediately after such event.
No  adjustment  of the  Exercise  Price  shall  be  made if the  amount  of such
adjustment  shall be less

                                       2
<PAGE>

than $.05 per Share;  but any such adjustment not required then to be made shall
be  carried  forward  and  shall be made at the time and  together  with the any
subsequent  adjustment(s)  which,  together  with any  adjustment(s)  so carried
forward, shall amount to not less than $.05 per Share.

     (b) Number of Shares Issuable on Exercise of Warrants. Upon each adjustment
of the Exercise  Price  pursuant to this  Section,  the Holder shall  thereafter
(until  another  such  adjustment)  be entitled  to  purchase,  at the  adjusted
Exercise  Price,  the number of Shares,  calculated  to the nearest  full Share,
equal to the  quotient of (i) the  product of (A) the number of Shares  issuable
under this  Warrant  (as then  adjusted  pursuant  hereto  prior to the  current
adjustment),  multiplied  by (B) the  Exercise  Price  in  effect  prior to such
adjustment, divided by (ii) the adjusted Exercise Price.

     (c) Notice of Adjustment. Upon any adjustment of the Exercise Price and any
increase or decrease in the number of Shares of Common Stock  issuable  upon the
exercise of the Warrant,  then,  and in each such case, the Company shall within
30 days  thereafter give written notice thereof,  by first-class  mail,  postage
prepaid, addressed to each Holder as shown on the books of the Company. Any such
notice shall state the  adjusted  Exercise  Price and adjusted  number of Shares
issuable  upon the  exercise of the Warrant,  and shall set forth in  reasonable
detail the methods of calculation of such  adjustments  and the facts upon which
such calculations were based.

     (d) Effect of  Reorganization,  Reclassification  or Merger. If at any time
while this Warrant is outstanding there should be (i) any  reorganization of the
Company's  capital  stock  (other than splits or  combinations  of Common  Stock
contemplated  by and provided for in Section 4(a)),  (ii) any  consolidation  or
merger of the Company  with  another  corporation,  limited  liability  company,
partnership or other business entity,  or any sale,  conveyance,  lease or other
transfer by the Company of all or substantially all of its property to any other
corporation,  limited liability  company,  partnership or other business entity,
which is effected  in such a manner  that the  holders of Common  Stock shall be
entitled to receive  cash,  stock,  securities  or assets with  respect to or in
exchange for Common Stock, or (iii) any dividend or any other  distribution upon
any class of the Company's capital stock payable in capital stock of a different
class,  other  securities of the Company,  or other Company property (other than
cash),  then, as a part of such  transaction,  lawful provision shall be made so
that  Holder  shall have the right  thereafter  to  receive,  upon the  exercise
hereof,  the number of shares of stock or other  securities  or  property of the
Company or of the successor entity resulting from a consolidation or merger,  or
of the entity to which the  property  of the  Company  has been sold,  conveyed,
leased or otherwise transferred, as the case may be, which the Holder would have
been entitled to receive upon such capital  reorganization,  reclassification of
capital stock, consolidation, merger, sale, conveyance, lease or other transfer,
if  this  Warrant  had  been  exercised   immediately   prior  to  such  capital
reorganization,  reclassification of capital stock, consolidation, merger, sale,
conveyance,  lease or other transfer. In any such case, appropriate  adjustments
(as  determined  by the  Company's  board  of  directors)  shall  be made in the
application of the provisions of this Warrant to the end that the provisions set
forth herein shall  thereafter be  applicable,  as near as reasonably may be, in
relation  to any  shares  or  other  property  thereafter  deliverable  upon the
exercise of the Warrant as if the Warrant had been exercised  immediately  prior
to  such  capital  reorganization,   reclassification  of  capital  stock,  such
consolidation,  merger, sale, conveyance, lease or other transfer and the Holder
had  carried  out the terms of the  exchange  as  provided  for by such  capital
reorganization,  consolidation or merger.  The Company shall not effect any such
capital reorganization,  consolidation, merger or transfer unless, upon or prior
to the  consummation  thereof,  the successor  entity or the entity to which the
property of the Company has been sold, conveyed, leased or otherwise transferred
shall assume in writing the  obligation  to deliver to the Holder such shares of
stock,  securities,  cash or  property  which the Holder  shall be  entitled  to
purchase in accordance with the foregoing provisions.

     5. No Rights as  Shareholder.  This  Warrant  shall not  entitle the Holder
hereof to any voting rights or other rights as a shareholder of the Company.

                                       3
<PAGE>

     6.  Governing  Law.  This  Warrant  shall be governed by and  construed  in
accordance  with  the laws of the  State  of  Minnesota  without  regard  to its
conflicts-of-law provisions.

     7.  Amendments  and  Waivers.  The  provisions  of this  Warrant may not be
amended, modified or supplemented, and waiver or consents to departures from the
provisions hereof may not be given, unless the Company agrees in writing and has
obtained the written consent of the Holder.

     8.  Successors  and Assigns.  All the terms and  conditions of this Warrant
shall be binding upon and inure to the benefit of the permitted  successors  and
assigns of the Company and Holder.

     9.  Headings  and  References.   The  headings  of  this  Warrant  are  for
convenience only and shall not affect the interpretation of this Warrant. Unless
the  context  indicates  otherwise,   all  references  herein  to  Sections  are
references to Sections of this Warrant.

     10.  Notices.  All notices or  communications  hereunder,  except as herein
otherwise specifically provided, shall be in writing. Notices sent to the Holder
shall be mailed, hand delivered or faxed and confirmed to the Holder at his, her
or its address set forth in the Company's  records.  Notices sent to the Company
shall be mailed,  hand  delivered or faxed and confirmed to  ProUroCare  Medical
Inc., One Carlson  Parkway,  Suite 124,  Plymouth,  Minnesota  55447, or to such
other address as the Company or the Holder shall notify the other as provided in
this Section.

     IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer on the date first set forth above.

PROUROCARE MEDICAL INC.

By:  /s/Michael P. Grossman
  -------------------------------------
    MICHAEL P. GROSSMAN, President

ATTEST:

By:  /s/Richard B. Thon
  -------------------------------------
  RICHARD THON, Chief Financial Officer

<PAGE>EXHIBIT 4.3
                                                                     -----------

THE  WARRANT  AND  THE  SECURITIES   ISSUABLE  UPON  EXERCISE  OF  THIS  WARRANT
(COLLECTIVELY,  THE "SECURITIES")  HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER ANY STATE SECURITIES OR
BLUE  SKY LAWS  ("BLUE  SKY  LAWS").  NO  TRANSFER,  SALE,  ASSIGNMENT,  PLEDGE,
HYPOTHECATION  OR OTHER  DISPOSITION  OF THIS WARRANT OR THE  SECURITIES  OR ANY
INTEREST  THEREIN MAY BE MADE EXCEPT (A) PURSUANT TO AN  EFFECTIVE  REGISTRATION
STATEMENT  UNDER THE SECURITIES  ACT AND ANY APPLICABLE  BLUE SKY LAWS OR (B) IF
THE COMPANY HAS BEEN  FURNISHED  WITH BOTH AN OPINION OF COUNSEL FOR THE HOLDER,
WHICH OPINION AND COUNSEL SHALL BE  SATISFACTORY  TO THE COMPANY,  TO THE EFFECT
THAT NO  REGISTRATION  IS REQUIRED  BECAUSE OF THE  AVAILABILITY OF AN EXEMPTION
FROM  REGISTRATION  UNDER THE SECURITIES  ACT AND APPLICABLE  BLUE SKY LAWS, AND
ASSURANCES THAT THE TRANSFER, SALE, ASSIGNMENT,  PLEDGE,  HYPOTHECATION OR OTHER
DISPOSITION  WILL BE MADE ONLY IN  COMPLIANCE  WITH THE  CONDITIONS  OF ANY SUCH
REGISTRATION OR EXEMPTION.

                   WARRANT TO PURCHASE SHARES OF COMMON STOCK
                                       OF
                             PROUROCARE MEDICAL INC.

Warrant No. ____                                             Plymouth, Minnesota
                                                                   July 19, 2004

     THIS CERTIFIES THAT, for value received, Artann Laboratories,  Inc., or its
successors or assigns (collectively,  the "Holder") is entitled to purchase from
ProUroCare Medical Inc. (the "Company"), Ninety Thousand (90,000) fully paid and
nonassessable  shares (the "Shares") of the Company's common stock,  $.00001 par
value (the  "Common  Stock"),  at an  exercise  price of Two  Dollars and No/100
($2.00)  per Share  (the  "Exercise  Price"),  subject to  adjustment  as herein
provided.  This warrant shall be exercisable only to the extent that all, or any
part thereof,  has vested in the Holder. This Warrant may be exercised by Holder
at any time after the date hereof;  provided,  however, that, Holder shall in no
event have the right to exercise this Warrant or any portion  thereof after five
years from the date hereof, at which time all of Holder's rights hereunder shall
expire.

     This Warrant is subject to the following provisions, terms and conditions:

     1.  Vesting.  The warrant  shall vest on a pro rata basis in equal  monthly
installments  over a thirty-six (36) month period,  beginning on the date of the
first  month  anniversary  of the date of this  warrant and  continuing  on each
monthly anniversary date (hereinafter referred to singularly as a "Vesting Date"
and collectively as "Vesting Dates") until the warrant is fully vested.

     2.  Exercise  of Warrant.  The rights  represented  by this  Warrant may be
exercised  by the  Holder,  in  whole or in part  (but not as to any  fractional
shares of Common Stock), by the surrender of this Warrant (properly endorsed, if
required,  at the Company's  principal  office in Plymouth,  Minnesota,  or such
other office or agency of the Company as the Company may  designate by notice in
writing to the Holder at the  address of such Holder  appearing  on the books of
the Company at any time within the period above  named),  and upon payment to it
by certified  check,  bank draft or cash of the purchase  price for such Shares.
The Company agrees that the Shares so purchased  shall be deemed to be issued to
the Holder as the record owner of such Shares as of the close of business on the
date on which this  Warrant

<PAGE>

shall have been  surrendered and payment for such Shares shall have been made as
aforesaid.  Certificates  for the Shares so purchased  shall be delivered to the
Holder  within a  reasonable  time,  not  exceeding  30 days,  after the  rights
represented  by this  Warrant  shall have been so  exercised  and,  unless  this
Warrant has expired,  a new Warrant  representing the number of Shares,  if any,
with respect to which this Warrant shall not then have been exercised shall also
be  delivered to the Holder  within such time.  The Company may require that any
such new  Warrant or any  certificate  for Shares  purchased  upon the  exercise
hereof bear a legend  substantially  similar to that which is  contained  on the
face of this Warrant.

     3.  Transferability  of this  Warrant.  This  Warrant  is  issued  upon the
following terms, to which Holder consents and agrees:

     (a) Until this  Warrant is  transferred  on the books of the  Company,  the
Company will treat the Holder of this  Warrant,  registered as such on the books
of the Company,  as the absolute  owner hereof for all purposes  without  effect
given to any notice to the contrary.

     (b) This  Warrant  may not be  exercised,  and this  Warrant and the Shares
underlying this Warrant shall not be transferable, except in compliance with all
applicable state and federal  securities laws,  regulations and orders, and with
all other applicable laws, regulations and orders.

     (c) The  Warrant  may not be  transferred,  and the  Shares  issuable  upon
exercise of this Warrant, may not be transferred without the Holder obtaining an
opinion of counsel,  which opinion and counsel are  satisfactory to the Company,
stating  that  the  proposed   transaction  will  not  result  in  a  prohibited
transaction  under the Securities Act and applicable Blue Sky Laws. By accepting
this Warrant, the Holder agrees to act in accordance with any conditions imposed
on such transfer by any such opinion of counsel.

     (d) Neither the  issuance  of this  Warrant nor the  issuance of the Shares
issuable upon exercise of this Warrant have been registered under the Securities
Act.

     4. Certain Covenants of the Company.  The Company covenants and agrees that
all Shares  which may be issued upon the exercise of the rights  represented  by
this Warrant,  upon issuance and full payment for the Shares so purchased,  will
be duly authorized and issued,  fully paid and  nonassessable  and free from all
taxes, liens and charges with respect to the issue hereof, except those that may
be created by or imposed upon the Holder or its property;  and, without limiting
the generality of the foregoing,  the Company  covenants and agrees that it will
from time to time take all such  actions as may be  required  to ensure that the
par value per share of the  Common  Stock is at all times  equal to or less than
the Exercise  Price per Share  issuable  pursuant to this  Warrant.  The Company
further  covenants  and agrees  that during the period  within  which the rights
represented by this Warrant may be exercised, the Company will at all times have
authorized and reserved,  free of preemptive or other rights, for the purpose of
issue  upon  exercise  of the  purchase  rights  evidenced  by this  Warrant,  a
sufficient number of shares of its Common Stock to provide for the full exercise
of the rights represented by this Warrant.

     5.  Adjustment of Exercise  Price and Number of Shares.  The Exercise Price
and number of Shares are subject to the following adjustments:

     (a) Stock Dividend, Stock Split or Stock Combination.  If (i) any dividends
on any  class  of the  Company's  capital  stock  payable  in  Common  Stock  or
securities  convertible  into or  exercisable  for Common  Stock  (collectively,
"Common Stock Equivalents") shall be paid by the Company, (ii) the Company shall
divide its  then-outstanding  shares of Common  Stock  into a greater  number of
shares,  or (iii) the Company  shall  combine its  outstanding  shares of Common
Stock, by reclassification  or otherwise,  then, in any such event, the Exercise
Price in effect  immediately  prior to such event shall  (until

                                       2
<PAGE>

adjusted again pursuant  hereto) be adjusted  immediately  after such event to a
price  (calculated  to the nearest  full cent) equal to the  quotient of (x) the
number of shares of Common Stock  outstanding  immediately  prior to such event,
multiplied  by the  Exercise  Price in effect  immediately  prior to such event,
divided  by  (y)  the  total  number  of  shares  of  Common  Stock  outstanding
immediately  after such event. No adjustment of the Exercise Price shall be made
if the amount of such adjustment shall be less than $.05 per Share; but any such
adjustment  not required  then to be made shall be carried  forward and shall be
made at the  time and  together  with the any  subsequent  adjustment(s)  which,
together with any  adjustment(s)  so carried  forward,  shall amount to not less
than $.05 per Share.

     (b) Number of Shares Issuable on Exercise of Warrants. Upon each adjustment
of the Exercise  Price  pursuant to this  Section,  the Holder shall  thereafter
(until  another  such  adjustment)  be entitled  to  purchase,  at the  adjusted
Exercise  Price,  the number of Shares,  calculated  to the nearest  full Share,
equal to the  quotient of (i) the  product of (A) the number of Shares  issuable
under this  Warrant  (as then  adjusted  pursuant  hereto  prior to the  current
adjustment),  multiplied  by (B) the  Exercise  Price  in  effect  prior to such
adjustment, divided by (ii) the adjusted Exercise Price.

     (c) Notice of Adjustment. Upon any adjustment of the Exercise Price and any
increase or decrease in the number of Shares of Common Stock  issuable  upon the
exercise of the Warrant,  then,  and in each such case, the Company shall within
30 days  thereafter give written notice thereof,  by first-class  mail,  postage
prepaid, addressed to each Holder as shown on the books of the Company. Any such
notice shall state the  adjusted  Exercise  Price and adjusted  number of Shares
issuable  upon the  exercise of the Warrant,  and shall set forth in  reasonable
detail the methods of calculation of such  adjustments  and the facts upon which
such calculations were based.

     (d) Effect of  Reorganization,  Reclassification  or Merger. If at any time
while this Warrant is outstanding there should be (i) any  reorganization of the
Company's  capital  stock  (other than splits or  combinations  of Common  Stock
contemplated  by and provided for in Section 5(a)),  (ii) any  consolidation  or
merger of the Company  with  another  corporation,  limited  liability  company,
partnership or other business entity,  or any sale,  conveyance,  lease or other
transfer by the Company of all or substantially all of its property to any other
corporation,  limited liability  company,  partnership or other business entity,
which is effected  in such a manner  that the  holders of Common  Stock shall be
entitled to receive  cash,  stock,  securities  or assets with  respect to or in
exchange for Common Stock, or (iii) any dividend or any other  distribution upon
any class of the Company's capital stock payable in capital stock of a different
class,  other  securities of the Company,  or other Company property (other than
cash),  then, as a part of such  transaction,  lawful provision shall be made so
that  Holder  shall have the right  thereafter  to  receive,  upon the  exercise
hereof,  the number of shares of stock or other  securities  or  property of the
Company or of the successor entity resulting from a consolidation or merger,  or
of the entity to which the  property  of the  Company  has been sold,  conveyed,
leased or otherwise transferred, as the case may be, which the Holder would have
been entitled to receive upon such capital  reorganization,  reclassification of
capital stock, consolidation, merger, sale, conveyance, lease or other transfer,
if  this  Warrant  had  been  exercised   immediately   prior  to  such  capital
reorganization,  reclassification of capital stock, consolidation, merger, sale,
conveyance,  lease or other transfer. In any such case, appropriate  adjustments
(as  determined  by the  Company's  board  of  directors)  shall  be made in the
application of the provisions of this Warrant to the end that the provisions set
forth herein shall  thereafter be  applicable,  as near as reasonably may be, in
relation  to any  shares  or  other  property  thereafter  deliverable  upon the
exercise of the Warrant as if the Warrant had been exercised  immediately  prior
to  such  capital  reorganization,   reclassification  of  capital  stock,  such
consolidation,  merger, sale, conveyance, lease or other transfer and the Holder
had  carried  out the terms of the  exchange  as  provided  for by such  capital
reorganization,  consolidation or merger.  The Company shall not effect any such
capital reorganization,  consolidation, merger or transfer unless, upon or prior
to the  consummation  thereof,  the successor  entity or the entity to which the
property of the Company has been sold, conveyed, leased or otherwise transferred
shall assume in writing the  obligation  to deliver to the Holder such shares of
stock,  securities,  cash or  property  which the Holder  shall be  entitled  to
purchase in accordance with the foregoing provisions.

                                       3
<PAGE>

     6. No Rights as  Shareholder.  This  Warrant  shall not  entitle the Holder
hereof to any voting rights or other rights as a shareholder of the Company.

     7.  Governing  Law.  This  Warrant  shall be governed by and  construed  in
accordance  with  the laws of the  State  of  Minnesota  without  regard  to its
conflicts-of-law provisions.

     8.  Amendments  and  Waivers.  The  provisions  of this  Warrant may not be
amended, modified or supplemented, and waiver or consents to departures from the
provisions hereof may not be given, unless the Company agrees in writing and has
obtained the written consent of the Holder.

     9.  Successors  and Assigns.  All the terms and  conditions of this Warrant
shall be binding upon and inure to the benefit of the permitted  successors  and
assigns of the Company and Holder.

     10.  Headings  and  References.  The  headings  of  this  Warrant  are  for
convenience only and shall not affect the interpretation of this Warrant. Unless
the  context  indicates  otherwise,   all  references  herein  to  Sections  are
references to Sections of this Warrant.

     11.  Notices.  All notices or  communications  hereunder,  except as herein
otherwise specifically provided, shall be in writing. Notices sent to the Holder
shall be mailed, hand delivered or faxed and confirmed to the Holder at his, her
or its address set forth in the Company's  records.  Notices sent to the Company
shall be mailed,  hand  delivered or faxed and confirmed to  ProUroCare  Medical
Inc., One Carlson  Parkway,  Suite 124,  Plymouth,  Minnesota  55447, or to such
other address as the Company or the Holder shall notify the other as provided in
this Section.

     IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer on the date first set forth above.

PROUROCARE MEDICAL INC.

By:   /s/Michael Grossman
  --------------------------------------
  MICHAEL P. GROSSMAN, President and CEO

ATTEST:

By:   /s/Richard Thon
  --------------------------------------
  RICHARD THON, Chief Financial Officer

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00069-of-00352.parquet"}]]